drugset / Trial / NCT01804777
Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
Phase 0
Terminated
9 enrolled
University of New Mexico
Dialysis Clinic, Inc. · collabUniversity of Pittsburgh · collab
RandomizedCrossoverDouble-blindHealth-services research
Summary
The purpose of this study is to determine with the administration of amiloride, observe an enhanced natriuresis, reduction in blood pressure and weight compared to the administration of hydrochlorothiazide in Type 2 Diabetics.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-12
- Completion
- 2014-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amiloride | Small molecule | 20 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | — |